These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38849266)

  • 1. Complete versus culprit-only percutaneous coronary intervention in elderly patients with acute coronary syndrome and multivessel coronary artery disease: A systematic review and meta-analysis.
    Franco AJ; Krishna MM; Joseph M; Ezenna C; Bakir ZE; Sudo RYU; Wippel CW; Ismayl M; Goldsweig AM; Uthirapathy I
    Cardiovasc Revasc Med; 2024 Jun; ():. PubMed ID: 38849266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials.
    Bajraktari G; Bytyçi I; Henein MY; Alfonso F; Ahmed A; Jashari H; Bhatt DL
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100549. PubMed ID: 32577495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of immediate complete vs staged complete revascularization in patients with acute coronary syndrome and multivessel disease.
    Singh S; Garg A; Chaudhary R; Rout A; Tantry US; Bliden K; Gurbel PA
    Cardiovasc Revasc Med; 2024 Mar; 60():1-8. PubMed ID: 37813709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials.
    Xu H; Zhang X; Li J; Liu H; Hu X; Yang J
    BMC Cardiovasc Disord; 2019 Apr; 19(1):91. PubMed ID: 31010423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Levett JY; Windle SB; Filion KB; Cabaussel J; Eisenberg MJ
    Am J Cardiol; 2020 Nov; 135():40-49. PubMed ID: 32871112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials.
    Feng Y; Li S; Hu S; Wan J; Shao H
    Front Cardiovasc Med; 2022; 9():1000664. PubMed ID: 36225962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials.
    Dahal K; Rijal J; Panta R; Lee J; Azrin M; Lootens R
    Cardiovasc Revasc Med; 2014; 15(8):408-13. PubMed ID: 25454258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.
    Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA
    JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Song YJ; Shin HC; Yang JI; Lee HY; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Jang JS
    J Interv Cardiol; 2015 Feb; 28(1):1-13. PubMed ID: 25689544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and multivessel disease patients undergoing primary percutaneous coronary intervention: A meta-analysis and trial sequential analysis.
    Wang CH; Zhang SY; Jin XF
    Int J Cardiol; 2017 Feb; 228():844-852. PubMed ID: 27907885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
    Elgendy IY; Wen X; Mahmoud A; Bavry AA
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
    Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR
    JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate Versus Staged Complete Revascularization in Patients Presenting with Acute Coronary Syndrome and Multivessel Coronary Disease Without Cardiac Shock: A Study-Level Meta-analysis of Randomized Controlled Trials.
    Zhou YM; Sun B
    Cardiovasc Drugs Ther; 2024 Jun; ():. PubMed ID: 38884921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culprit vessel versus immediate complete revascularization in patients with ST-segment myocardial infarction-a systematic review.
    Spencer FA; Sekercioglu N; Prasad M; Lopes LC; Guyatt GH
    Am Heart J; 2015 Dec; 170(6):1133-9. PubMed ID: 26678635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Versus Culprit-Only Revascularization in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Salih M; Ibrahim AM; Al-Akchar M; Bhattarai M; Koester C; Ayan M; Hafiz AM
    Cardiovasc Revasc Med; 2020 Dec; 21(12):1482-1488. PubMed ID: 32571757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.